NCT05821036 is a NA clinical trial of Activitiy Management in Fibromyalgia, sponsored by Ankara Medipol University.

Who is sponsoring NCT05821036?

NCT05821036 is sponsored by Ankara Medipol University.

What drugs are being tested in NCT05821036?

Interventions in NCT05821036: Activitiy Management.

What condition does NCT05821036 study?

NCT05821036 studies Fibromyalgia.

Is NCT05821036 still recruiting?

NCT05821036 is currently status unknown. Last updated 20 April 2023.

Last reviewed 2023-04-20 · How we verify

NCT05821036

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Examining the Effects of Activity Management in Women With Fibromyalgia Syndrome

Status unknown NA Last updated 20 April 2023

What this trial tests

NA trial testing Activitiy Management in Fibromyalgia in 30 participants. Status unknown.

Timeline

27 June 2022

Primary endpoint
27 December 2023

27 December 2023

Quick facts

Lead sponsor	Ankara Medipol University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	27 June 2022
Primary completion	27 December 2023
Estimated completion	27 December 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Activitiy Management

Conditions studied

Fibromyalgia — all drugs for Fibromyalgia →

Sponsor

Ankara Medipol University

Who can join

Adults 18 to 64, female only, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: To determine the effects of activity management training on pain, occupational performance, quality of life, depression, anxiety and occupational balance in women with fibromyalgia syndrome (FMS). In addition to, reducing pain, which is the main symptom of FMS, by regulating the activity-rest cycle, it is aimed to increase people's participation in daily life and improve their quality of life. Method: A randomized controlled trial. A total of 10 sessions of individual-internet-based activity management training are applied to women with FMS in the intervention group, 2 sessions a week for 5 weeks, 1st and 10th sessions are pre- and post-training evaluation. Assessments before and after training The Revised Fibromyalgia Impact Questionnaire (FIQR), Canadian Occupational Performance Measure(COPM), Pain-activity patterns scale (Pomp/APPS) ,Nottingham Health Profile,The hospital anxiety and depression scale,The Occupational Balance Questionnaire (OBQ) is applied.Although no intervention is applied to the control group, only preliminary and final evaluations are completed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting

Other Ankara Medipol University trials

Trials by the same sponsor.

NCT07307885 — The Effect of Photobiomodulation on Pressure Ulcers · NA · not yet recruiting
NCT07304609 — "Effect of LEGO® Serious Play® Trauma-Informed Care Training on Nursing Students · NA · not yet recruiting
NCT07344857 — Prenatal Pilates and Postpartum Ligamentous Laxity · completed
NCT06765304 — Preconceptional Period and Transtheoretically Based Education · NA · completed
NCT07133009 — Intentional Relationship Model in OT Students · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05821036 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara Medipol University
Last refreshed: 20 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05821036.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing